796
Views
89
CrossRef citations to date
0
Altmetric
Original Research

Expression of Cox-2 in human breast cancer cells as a critical determinant of epithelial-to-mesenchymal transition and invasiveness

, , , , , , , , , , & show all

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Xuhan Yang, Zhonglu Niu, Xiaorui Wang, Xiaoming Lu, Jinyue Sun, M. Carpena, M.A. Prieto, Jesus Simal-Gandara, Jianbo Xiao, Chao Liu & Ningyang Li. (2022) The Nutritional and Bioactive Components, Potential Health Function and Comprehensive Utilization of Pomegranate: A Review. Food Reviews International 0:0, pages 1-27.
Read now
Margarita Papadopoulou, Helen Papadaki, Vasiliki Zolota & Sotirios P. Gartaganis. (2017) Immunohistochemical Profiles of LOXL-1, FBN1, TGF-β1, and COX-2 in Pseudoexfoliation Syndrome. Current Eye Research 42:6, pages 880-889.
Read now
M. Fahlén, H. Zhang, L. Löfgren, B. Masironi, E. von Schoultz, B. von Schoultz & L. Sahlin. (2017) Expression of cyclooxygenase-1 and cyclooxygenase-2, syndecan-1 and connective tissue growth factor in benign and malignant breast tissue from premenopausal women. Gynecological Endocrinology 33:5, pages 353-358.
Read now
Moataz Ehab & Mohamad Elbaz. (2016) Profile of palbociclib in the treatment of metastatic breast cancer. Breast Cancer: Targets and Therapy 8, pages 83-91.
Read now
Ping Zhang, He-Sheng Luo, Ming Li & Shi-yun Tan. (2015) Artesunate inhibits the growth and induces apoptosis of human gastric cancer cells by downregulating COX-2. OncoTargets and Therapy 8, pages 845-854.
Read now

Articles from other publishers (84)

Jef Haerinck, Steven Goossens & Geert Berx. (2023) The epithelial–mesenchymal plasticity landscape: principles of design and mechanisms of regulation. Nature Reviews Genetics 24:9, pages 590-609.
Crossref
Ahmed M. Shawky, Faisal A. Almalki, Ashraf N. Abdalla, Bahaa GM. Youssif, Maha M. Abdel-Fattah, Fatima Hersi, Hany A.M. El-Sherief, Nashwa, A. Ibrahim & Ahmed M. Gouda. (2023) Discovery and optimization of 2,3-diaryl-1,3-thiazolidin-4-one-based derivatives as potent and selective cytotoxic agents with anti-inflammatory activity. European Journal of Medicinal Chemistry, pages 115712.
Crossref
Aranka Brockmueller, Sosmitha Girisa, Mahzad Motallebi, Ajaikumar B. Kunnumakkara & Mehdi Shakibaei. (2023) Calebin A targets the HIF-1α/NF-κB pathway to suppress colorectal cancer cell migration. Frontiers in Pharmacology 14.
Crossref
Kuppusamy Balamurugan, Dipak K. Poria, Saadiya W. Sehareen, Savitri Krishnamurthy, Wei Tang, Lois McKennett, Veena Padmanaban, Kelli Czarra, Andrew J. Ewald, Naoto T. Ueno, Stefan Ambs, Shikha Sharan & Esta Sterneck. (2023) Stabilization of E-cadherin adhesions by COX-2/GSK3β signaling is a targetable pathway in metastatic breast cancer. JCI Insight 8:6.
Crossref
Shilpi Singh, Akhilesh Kumar Maurya, Abha Meena, Nidhi Mishra & Suaib Luqman. (2023) Narirutin downregulates lipoxygenase-5 expression and induces G0/G1 arrest in triple-negative breast carcinoma cells. Biochimica et Biophysica Acta (BBA) - General Subjects, pages 130340.
Crossref
Alice Johnson, Chibuzor Olelewe, Jong Hyun Kim, Joshua Northcote-Smith, R. Tyler Mertens, Ginevra Passeri, Kuldip Singh, Samuel G. Awuah & Kogularamanan Suntharalingam. (2023) The anti-breast cancer stem cell properties of gold( i )-non-steroidal anti-inflammatory drug complexes . Chemical Science 14:3, pages 557-565.
Crossref
A. Alonso-Diez, V.K. Affolter, N. Sevane, S. Dunner, G. Valdivia, M. Clemente, P.J. De Andrés, J.C. Illera, M.D. Pérez-Alenza & L. Peña. (2022) Cell adhesion molecules E-cadherin and CADM1 are differently expressed in canine inflammatory mammary cancer. Research in Veterinary Science 152, pages 307-313.
Crossref
Qi Liu, Chengcheng Guan, Cui Liu, Huayao Li, Jibiao Wu & Changgang Sun. (2022) Targeting hypoxia-inducible factor-1alpha: A new strategy for triple-negative breast cancer therapy. Biomedicine & Pharmacotherapy 156, pages 113861.
Crossref
Rituparna Ghosh, Priya Samanta, Rupali Sarkar, Souradeep Biswas, Prosenjit Saha, Subhadip Hajra & Arijit Bhowmik. (2022) Targeting HIF-1α by Natural and Synthetic Compounds: A Promising Approach for Anti-Cancer Therapeutics Development. Molecules 27:16, pages 5192.
Crossref
Kaustav Banerjee, Debojit Bhattacherjee, Khyati Raina, Rajkumar P. Thummer & Krishna Pada Bhabak. (2022) Benzimidazole-based ionic and non-ionic organoselenium compounds: innovative synthetic strategies, structural characterization and preliminary anti-proliferative activities. New Journal of Chemistry 46:24, pages 11910-11926.
Crossref
Chen-Yu Zhang, Xin-Xin Guan, Zhuo-Hui Song, Hui-Ling Jiang, Yu-Biao Liu, Ping Chen, Jia-Xi Duan & Yong Zhou. (2022) COX-2/sEH Dual Inhibitor PTUPB Attenuates Epithelial-Mesenchymal Transformation of Alveolar Epithelial Cells via Nrf2-Mediated Inhibition of TGF-β1/Smad Signaling. Oxidative Medicine and Cellular Longevity 2022, pages 1-21.
Crossref
Renata Paprocka, Małgorzata Wiese-Szadkowska, Sabina Janciauskiene, Tomasz Kosmalski, Marcelina Kulik & Anna Helmin-Basa. (2022) Latest developments in metal complexes as anticancer agents. Coordination Chemistry Reviews 452, pages 214307.
Crossref
Riadh Badraoui, Mohd Saeed, Nouha Bouali, Walid S. Hamadou, Salem Elkahoui, Mohammad J. Alam, Arif J. Siddiqui, Mohd Adnan, Mongi Saoudi & Tarek Rebai. (2022) Expression Profiling of Selected Immune Genes and Trabecular Microarchitecture in Breast Cancer Skeletal Metastases Model: Effect of α–Tocopherol Acetate Supplementation. Calcified Tissue International 110:4, pages 475-488.
Crossref
Hina Agraval, Jiten R. Sharma, Nutan Prakash & Umesh C.S. Yadav. (2022) Fisetin suppresses cigarette smoke extract-induced epithelial to mesenchymal transition of airway epithelial cells through regulating COX-2/MMPs/β-catenin pathway. Chemico-Biological Interactions 351, pages 109771.
Crossref
Jun Tian, Vivian Wang, Ni Wang, Baharak Khadang, Julien Boudreault, Khldoun Bakdounes, Suhad Ali & Jean-Jacques Lebrun. (2021) Identification of MFGE8 and KLK5/7 as mediators of breast tumorigenesis and resistance to COX-2 inhibition. Breast Cancer Research 23:1.
Crossref
Ming-Yu Chou & Muh-Hwa Yang. (2021) Interplay of Immunometabolism and Epithelial–Mesenchymal Transition in the Tumor Microenvironment. International Journal of Molecular Sciences 22:18, pages 9878.
Crossref
Tatiany L. Silveira, Lisa Y. Pang, Alexandra Di Domenico, Emerson S. Veloso, Istéfani L. D. Silva, Helen L. Del Puerto, Enio Ferreria & David J. Argyle. (2021) COX-2 Silencing in Canine Malignant Melanoma Inhibits Malignant Behaviour. Frontiers in Veterinary Science 8.
Crossref
Fernán Gómez-Valenzuela, Enrico Escobar, Ricardo Pérez-Tomás & Viviana P. Montecinos. (2021) The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition. Frontiers in Oncology 11.
Crossref
Zhong-Ying Ma, Xue-Qing Song, Juan-Juan Hu, Dong-Bo Wang, Xiao-Jing Ding, Rui-Ping Liu, Miao-Liang Dai, Fan-Yin Meng & Jing-Yuan Xu. (2021) Ketoplatin in triple-negative breast cancer cells MDA-MB-231: High efficacy and low toxicity, and positive impact on inflammatory microenvironment. Biochemical Pharmacology 188, pages 114523.
Crossref
Phuong H.L. Tran, Beom-Jin Lee & Thao T.D. Tran. (2021) Current Studies of Aspirin as an Anticancer Agent and Strategies to Strengthen its Therapeutic Application in Cancer. Current Pharmaceutical Design 27:18, pages 2209-2220.
Crossref
Vrinda Gote, Anantha Ram Nookala, Pradeep Kumar Bolla & Dhananjay Pal. (2021) Drug Resistance in Metastatic Breast Cancer: Tumor Targeted Nanomedicine to the Rescue. International Journal of Molecular Sciences 22:9, pages 4673.
Crossref
Catherine J. Feld, Alice Johnson, Zhiyin Xiao & Kogularamanan Suntharalingam. (2020) Breast Cancer Stem Cell Potency of Nickel(II)‐Polypyridyl Complexes Containing Non‐steroidal Anti‐inflammatory Drugs. Chemistry – A European Journal 26:61, pages 14011-14017.
Crossref
Hyeongsun Moon, Dahihm Kim, Leanne R. Donahue & Andrew C. White. (2020) Phenotypic Plasticity of Cutaneous Squamous Cell Carcinoma Mediated by Cyclooxygenase-2. Journal of Investigative Dermatology 140:8, pages 1665-1669.e5.
Crossref
Yu-bao Lu, Tian-Jiao SunYu-tong Chen, Zong-Yan Cai, Jia-Yu Zhao, Feng Miao, Yong-na Yang & Shi-Xin Wang. (2020) Targeting the Epithelial-to-Mesenchymal Transition in Cancer Stem Cells for a Better Clinical Outcome of Glioma. Technology in Cancer Research & Treatment 19, pages 153303382094805.
Crossref
A. S. Komorowski & R. C. Pezo. (2019) Untapped “-omics”: the microbial metagenome, estrobolome, and their influence on the development of breast cancer and response to treatment. Breast Cancer Research and Treatment 179:2, pages 287-300.
Crossref
Rohan Kar, Niraj Kumar Jha, Saurabh Kumar Jha, Ankur Sharma, Sunny Dholpuria, Nidhi Asthana, Kundan Chaurasiya, Vivek Kumar Singh, Shuaib Burgee & Parma Nand. (2019) A “NOTCH” Deeper into the Epithelial-To-Mesenchymal Transition (EMT) Program in Breast Cancer. Genes 10:12, pages 961.
Crossref
Moustafa Fathy, Michael Atef Fawzy, Henning Hintzsche, Toshio Nikaido, Thomas Dandekar & Eman M. Othman. (2019) Eugenol Exerts Apoptotic Effect and Modulates the Sensitivity of HeLa Cells to Cisplatin and Radiation. Molecules 24:21, pages 3979.
Crossref
Alba Jiménez-Segovia, Alba Mota, Alejandro Rojo-Sebastián, Beatriz Barrocal, Angela Rynne-Vidal, María-Laura García-Bermejo, Raquel Gómez-Bris, Lukas J.A.C. Hawinkels, Pilar Sandoval, Ramon Garcia-Escudero, Manuel López-Cabrera, Gema Moreno-Bueno, Manuel Fresno & Konstantinos Stamatakis. (2019) Prostaglandin F2α-induced Prostate Transmembrane Protein, Androgen Induced 1 mediates ovarian cancer progression increasing epithelial plasticity. Neoplasia 21:11, pages 1073-1084.
Crossref
Nouf N. Mahmoud, Rana Abu-Dahab, Lama A. Hamadneh, Duaa Abuarqoub, Hanan Jafar & Enam A. Khalil. (2019) Insights into the Cellular Uptake, Cytotoxicity, and Cellular Death Modality of Phospholipid-Coated Gold Nanorods toward Breast Cancer Cell Lines. Molecular Pharmaceutics 16:10, pages 4149-4164.
Crossref
Arvin Eskandari & Kogularamanan Suntharalingam. (2019) A reactive oxygen species-generating, cancer stem cell-potent manganese( ii ) complex and its encapsulation into polymeric nanoparticles . Chemical Science 10:33, pages 7792-7800.
Crossref
Serena De Matteis, Matteo Canale, Alberto Verlicchi, Giuseppe Bronte, Angelo Delmonte, Lucio Crinò, Giovanni Martinelli & Paola Ulivi. (2019) Advances in Molecular Mechanisms and Immunotherapy Involving the Immune Cell-Promoted Epithelial-to-Mesenchymal Transition in Lung Cancer. Journal of Oncology 2019, pages 1-11.
Crossref
Yan Li, Jian Cao, Yidong Zhou, Feng Mao, Songjie Shen & Qiang Sun. (2019) Mammographic casting-type calcification is an independent prognostic factor in invasive breast cancer. Scientific Reports 9:1.
Crossref
Viji Remadevi, Lakshmi Mohan Lathika, Anjana Sasikumar Sujatha & Sreeja Sreeharshan. (2019) Ficus extract—A promising agent for antimammary tumorigenesis: A review on current status and future possibilities . Phytotherapy Research 33:6, pages 1597-1603.
Crossref
Hyunkoo Kang, Hyunwoo Kim, Sungmin Lee, HyeSook Youn & BuHyun Youn. (2019) Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT). International Journal of Molecular Sciences 20:8, pages 2042.
Crossref
Xue-Qing Song, Zhong-Ying Ma, Yi-Gang Wu, Miao-Liang Dai, Dong-Bo Wang, Jing-Yuan Xu & Yangzhong Liu. (2019) New NSAID-Pt(IV) prodrugs to suppress metastasis and invasion of tumor cells and enhance anti-tumor effect in vitro and in vivo. European Journal of Medicinal Chemistry 167, pages 377-387.
Crossref
Jinlin Cai, Liang Huang, Jun Huang, Liang Kang, Hongcheng Lin, Pinzhu Huang, Peixuan Zhu, Jianping Wang, Jianghui Dong, Liping Wang & Cory J. Xian. (2018) Associations between the cyclooxygenase‐2 expression in circulating tumor cells and the clinicopathological features of patients with colorectal cancer. Journal of Cellular Biochemistry 120:4, pages 4935-4941.
Crossref
Yu Han, Wei Guo, Tingting Ren, Yi Huang, Shidong Wang, Kuisheng Liu, Bingxin Zheng, Kang Yang, Hongliang Zhang & Xin Liang. (2019) Tumor-associated macrophages promote lung metastasis and induce epithelial-mesenchymal transition in osteosarcoma by activating the COX-2/STAT3 axis. Cancer Letters 440-441, pages 116-125.
Crossref
Patricia A. Thompson, Christina Preece & Alison T. Stopeck. 2019. Fundamentals of Cancer Prevention. Fundamentals of Cancer Prevention 543 606 .
Kaustav Banerjee, Ganesan Padmavathi, Debojit Bhattacherjee, Suchismita Saha, Ajaikumar B. Kunnumakkara & Krishna P. Bhabak. (2018) Potent anti-proliferative activities of organochalcogenocyanates towards breast cancer. Organic & Biomolecular Chemistry 16:45, pages 8769-8782.
Crossref
Lei Li, Yanping Lv & Dengfeng Yan. (2018) Inhibition of Ep3 attenuates migration and promotes apoptosis of non‑small cell lung cancer cells via suppression of TGF‑β/Smad signaling. Oncology Letters.
Crossref
Dali Tong, Qiuli Liu, Lin-ang Wang, Qiubo Xie, Jian Pang, Yiqiang Huang, Luofu Wang, Gaolei Liu, Dianzheng Zhang, Weihua Lan & Jun Jiang. (2018) The roles of the COX2/PGE2/EP axis in therapeutic resistance. Cancer and Metastasis Reviews 37:2-3, pages 355-368.
Crossref
Lindy L. Visser, Lotte E. Elshof, Michael Schaapveld, Koen van de Vijver, Emma J. Groen, Mathilde M. Almekinders, Carolien Bierman, Flora E. van Leeuwen, Emiel J. Rutgers, Marjanka K. Schmidt, Esther H. Lips & Jelle Wesseling. (2018) Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ —A Nested Case–Control Study . Clinical Cancer Research 24:15, pages 3593-3601.
Crossref
Yunli Zhang, Yanming Li, Hongling Li, Wei Chen & Wenen Liu. (2018) Clostridium difficile toxin B recombinant protein inhibits tumor growth and induces apoptosis through inhibiting Bcl-2 expression, triggering inflammatory responses and activating C-erbB-2 and Cox-2 expression in breast cancer mouse model. Biomedicine & Pharmacotherapy 101, pages 391-398.
Crossref
Akansha Jalota, Mukesh Kumar, Bhudev C. Das, Ajay K. Yadav, Kunzang Chosdol & Subrata Sinha. (2018) A drug combination targeting hypoxia induced chemoresistance and stemness in glioma cells. Oncotarget 9:26, pages 18351-18366.
Crossref
S. O'Grady & M.P. Morgan. (2018) Microcalcifications in breast cancer: From pathophysiology to diagnosis and prognosis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1869:2, pages 310-320.
Crossref
Elahe Motevaseli, Mohammad Reza Khorramizadeh, Jamshid Hadjati, Samad Farashi Bonab, Solat Eslami & Soudeh Ghafouri-Fard. (2018) Investigation of antitumor effects of Lactobacillus crispatus in experimental model of breast cancer in BALB/c mice . Immunotherapy 10:2, pages 119-129.
Crossref
Miłosz Regulski, Hanna Piotrowska-Kempisty, Wiesław Prukała, Zbigniew Dutkiewicz, Katarzyna Regulska, Beata Stanisz & Marek Murias. (2018) Synthesis, in vitro and in silico evaluation of novel trans -stilbene analogues as potential COX-2 inhibitors. Bioorganic & Medicinal Chemistry 26:1, pages 141-151.
Crossref
Xichun Hu, Wei Huang & Minhao Fan. (2017) Emerging therapies for breast cancer. Journal of Hematology & Oncology 10:1.
Crossref
Qing Shi, Zhou Jiang, Jingyi Yang, Yunlong Cheng, Yaqiong Pang, Ning Zheng, Jiahang Chen, Wenge Chen & Lee Jia. (2017) A Flavonoid Glycoside Compound from Murraya paniculata (L.) Interrupts Metastatic Characteristics of A549 Cells by Regulating STAT3/NF-κB/COX-2 and EGFR Signaling Pathways. The AAPS Journal 19:6, pages 1779-1790.
Crossref
Dehai Che, Shuai Zhang, Zihan Jing, Lihua Shang, Shi Jin, Fang Liu, Jing Shen, Yue Li, Jing Hu, Qingwei Meng & Yan Yu. (2017) Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE 2 /β-catenin signalling pathway. Molecular Immunology 90, pages 197-210.
Crossref
Animesh Mandal, Deepak Bhatia & Anupam Bishayee. (2017) Anti-Inflammatory Mechanism Involved in Pomegranate-Mediated Prevention of Breast Cancer: the Role of NF-κB and Nrf2 Signaling Pathways. Nutrients 9:5, pages 436.
Crossref
Felix Tönisen, Louisiane Perrin, Battuya Bayarmagnai, Koen van den Dries, Alessandra Cambi & Bojana Gligorijevic. (2017) EP4 receptor promotes invadopodia and invasion in human breast cancer. European Journal of Cell Biology 96:2, pages 218-226.
Crossref
Liliana Terrin, Marco Agostini, Mariagrazia Ruvoletto, Andrea Martini, Salvatore Pucciarelli, Chiara Bedin, Donato Nitti & Patrizia Pontisso. (2017) SerpinB3 upregulates the Cyclooxygenase-2 / β-Catenin positive loop in colorectal cancer. Oncotarget 8:9, pages 15732-15743.
Crossref
Jun Tian, Mahmood Y. Hachim, Ibrahim Y. Hachim, Meiou Dai, Chieh Lo, Fatmah Al Raffa, Suhad Ali & Jean Jacques Lebrun. (2017) Cyclooxygenase-2 regulates TGFβ-induced cancer stemness in triple-negative breast cancer. Scientific Reports 7:1.
Crossref
Sarfraz Ahmed, Siti Amrah Sulaiman & Nor Hayati Othman. (2017) Oral Administration of Tualang and Manuka Honeys Modulates Breast Cancer Progression in Sprague-Dawley Rats Model. Evidence-Based Complementary and Alternative Medicine 2017, pages 1-15.
Crossref
Chia-Ting Chang, You-Cheng Hseu, Varadharajan Thiyagarajan, Hui-Chi Huang, Li-Sung Hsu, Pei-Jane Huang, Jer-Yuh Liu, Jiunn-Wang Liao & Hsin-Ling Yang. (2017) Antrodia salmonea induces G2 cell-cycle arrest in human triple-negative breast cancer (MDA-MB-231) cells and suppresses tumor growth in athymic nude mice. Journal of Ethnopharmacology 196, pages 9-19.
Crossref
Sandrine Tury, Véronique Becette, Franck Assayag, Sophie Vacher, Camille Benoist, Maud Kamal, Elisabetta Marangoni, Ivan Bièche, Florence Lerebours & Céline Callens. (2016) Combination of COX-2 expression and PIK3CA mutation as prognostic and predictive markers for celecoxib treatment in breast cancer . Oncotarget 7:51, pages 85124-85141.
Crossref
A. Schaumann, W. Klene, Chr. Rosenstengel, F. Ringel, J. Tüttenberg & P. Vajkoczy. (2016) COXIBRAIN: results of the prospective, randomised, phase II/III study for the selective COX-2 inhibition in chronic subdural haematoma patients. Acta Neurochirurgica 158:11, pages 2039-2044.
Crossref
Anna Boss, Karen Bishop, Gareth Marlow, Matthew Barnett & Lynnette Ferguson. (2016) Evidence to Support the Anti-Cancer Effect of Olive Leaf Extract and Future Directions. Nutrients 8:8, pages 513.
Crossref
Amancio Carnero & Matilde Lleonart. (2016) The hypoxic microenvironment: A determinant of cancer stem cell evolution. BioEssays 38, pages S65-S74.
Crossref
Huei-Hsuan Cheng, Ling-Yun Chu, Li-Yi Chiang, Hua-Ling Chen, Cheng-Chin Kuo & Kenneth K. Wu. (2016) Inhibition of cancer cell epithelial mesenchymal transition by normal fibroblasts via production of 5-methoxytryptophan. Oncotarget 7:21, pages 31243-31256.
Crossref
Miłosz Regulski, Katarzyna Regulska, Wiesław Prukała, Hanna Piotrowska, Beata Stanisz & Marek Murias. (2016) COX-2 inhibitors: a novel strategy in the management of breast cancer. Drug Discovery Today 21:4, pages 598-615.
Crossref
Shankar Suman, Pradeep Kumar Sharma, Girish Rai, Sanjay Mishra, Deepika Arora, Prachi Gupta & Yogeshwer Shukla. (2016) Current perspectives of molecular pathways involved in chronic inflammation-mediated breast cancer. Biochemical and Biophysical Research Communications 472:3, pages 401-409.
Crossref
Suresh Kumar Poovathingal, Nataly Kravchenko-Balasha, Young Shik Shin, Raphael David Levine & James R. Heath. (2016) Critical Points in Tumorigenesis: A Carcinogen-Initiated Phase Transition Analyzed via Single-Cell Proteomics. Small 12:11, pages 1425-1431.
Crossref
Janine N. Boodram, Iain J. Mcgregor, Peter M. Bruno, Paul B. Cressey, Michael T. Hemann & Kogularamanan Suntharalingam. (2016) Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes. Angewandte Chemie International Edition 55:8, pages 2845-2850.
Crossref
Janine N. Boodram, Iain J. Mcgregor, Peter M. Bruno, Paul B. Cressey, Michael T. Hemann & Kogularamanan Suntharalingam. (2016) Breast Cancer Stem Cell Potent Copper(II)-Non-Steroidal Anti-Inflammatory Drug Complexes. Angewandte Chemie 128:8, pages 2895-2900.
Crossref
Madalin Marius MarganAndreea Adriana JitariuAnca Maria CimpeanCristian NicaMarius Raica. (2016) Molecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast Carcinogenesis. Journal of Breast Cancer 19:2, pages 99.
Crossref
Ovidiu Balacescu, Loredana Balacescu, Oana Virtic, Simona Visan, Claudia Gherman, Flaviu Drigla, Laura Pop, Gabriela Bolba-Morar, Carmen Lisencu, Bogdan Fetica, Oana Tudoran & Ioana Berindan-Neagoe. (2016) Blood Genome-Wide Transcriptional Profiles of HER2 Negative Breast Cancers Patients. Mediators of Inflammation 2016, pages 1-12.
Crossref
Arvin Eskandari, Janine N. Boodram, Paul B. Cressey, Chunxin Lu, Peter M. Bruno, Michael T. Hemann & Kogularamanan Suntharalingam. (2016) The breast cancer stem cell potency of copper( ii ) complexes bearing nonsteroidal anti-inflammatory drugs and their encapsulation using polymeric nanoparticles . Dalton Transactions 45:44, pages 17867-17873.
Crossref
Ge Qin, Fei Xu, Tao Qin, Qiufan Zheng, Dingbo Shi, Wen Xia, Yun Tian, Yanlai Tang, Jingshu Wang, Xiangshen Xiao, Wuguo Deng & Shusen Wang. (2015) Palbociclib inhibits epithelial-mesenchymal transition and metastasis in breast cancer via c-Jun/COX-2 signaling pathway. Oncotarget 6:39, pages 41794-41808.
Crossref
Runping Liu, Xiaojiaoyang Li, Xiaoyan Qiang, Lan Luo, Phillip B. Hylemon, Zhenzhou Jiang, Luyong Zhang & Huiping Zhou. (2015) Taurocholate Induces Cyclooxygenase-2 Expression via the Sphingosine 1-phosphate Receptor 2 in a Human Cholangiocarcinoma Cell Line. Journal of Biological Chemistry 290:52, pages 30988-31002.
Crossref
Abbas K. Samadi, Alan Bilsland, Alexandros G. Georgakilas, Amedeo Amedei, Amr Amin, Anupam Bishayee, Asfar S. Azmi, Bal L. Lokeshwar, Brendan Grue, Carolina Panis, Chandra S. Boosani, Deepak Poudyal, Diana M. Stafforini, Dipita Bhakta, Elena Niccolai, Gunjan Guha, H.P. Vasantha Rupasinghe, Hiromasa Fujii, Kanya Honoki, Kapil Mehta, Katia Aquilano, Leroy Lowe, Lorne J. Hofseth, Luigi Ricciardiello, Maria Rosa Ciriolo, Neetu Singh, Richard L. Whelan, Rupesh Chaturvedi, S. Salman Ashraf, H.M.C. Shantha Kumara, Somaira Nowsheen, Sulma I. Mohammed, W. Nicol Keith, William G. Helferich & Xujuan Yang. (2015) A multi-targeted approach to suppress tumor-promoting inflammation. Seminars in Cancer Biology 35, pages S151-S184.
Crossref
Honor J. Hugo, C. Saunders, R. G. Ramsay & E. W. Thompson. (2015) New Insights on COX-2 in Chronic Inflammation Driving Breast Cancer Growth and Metastasis. Journal of Mammary Gland Biology and Neoplasia 20:3-4, pages 109-119.
Crossref
Ka Kui Chan, Kyle B. Matchett, Paul M. McEnhill, El Habib Dakir, Mary Frances McMullin, Yahia El-Tanani, Laurence Patterson, Ahmed Faheem, Philip S. Rudland, Paul A. McCarron & Mohamed El-Tanani. (2015) Protein deregulation associated with breast cancer metastasis. Cytokine & Growth Factor Reviews 26:4, pages 415-423.
Crossref
Muhammad Waqas Usman, Fuwen Luo, Hailing Cheng, Jean J. Zhao & Pixu Liu. (2015) Chemopreventive effects of aspirin at a glance. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1855:2, pages 254-263.
Crossref
Sara Caceres, Laura Peña, Paloma J. de Andres, Maria J. Illera, Mirtha S. Lopez, Wendy A. Woodward, James M. Reuben & Juan C. Illera. (2015) Establishment and Characterization of a New Cell Line of Canine Inflammatory Mammary Cancer: IPC-366. PLOS ONE 10:3, pages e0122277.
Crossref
Ravindran Vini & Sreeharshan Sreeja. (2015) Punica granatum and its therapeutic implications on breast carcinogenesis: A review . BioFactors 41:2, pages 78-89.
Crossref
Yanuar Dwi Putra Limasale, Ayşen Tezcaner, Can Özen, Dilek Keskin & Sreeparna Banerjee. (2015) Epidermal growth factor receptor-targeted immunoliposomes for delivery of celecoxib to cancer cells. International Journal of Pharmaceutics 479:2, pages 364-373.
Crossref
Zhao-ji Liu, Gregg L. Semenza & Hua-feng Zhang. (2015) Hypoxia-inducible factor 1 and breast cancer metastasis低氧诱导因子与乳腺癌转移. Journal of Zhejiang University-SCIENCE B 16:1, pages 32-43.
Crossref
Tomas Koltai. (2015) Fenofibrate in cancer: mechanisms involved in anticancer activity. F1000Research 4, pages 55.
Crossref
Chun-Xiong Zhao, Chun-Li Luo & Xiao-Hou Wu. (2014) Hypoxia promotes 786-O cells invasiveness and resistance to sorafenib via HIF-2α/COX-2. Medical Oncology 32:1.
Crossref
Ming Li, Shi-Yun Tan & Xiao-Fan Wang. (2014) Paeonol exerts an anticancer effect on human colorectal cancer cells through inhibition of PGE2 synthesis and COX-2 expression. Oncology Reports.
Crossref
Felicity M. Davis, Teneale A. Stewart, Erik W. Thompson & Gregory R. Monteith. (2014) Targeting EMT in cancer: opportunities for pharmacological intervention. Trends in Pharmacological Sciences 35:9, pages 479-488.
Crossref
Randall E Harris. (2014) Cyclooxygenase-2 and the inflammogenesis of breast cancer. World Journal of Clinical Oncology 5:4, pages 677.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.